Literature DB >> 2965573

Intermediate forms of human beta-N-acetylhexosaminidase lack activity towards 4-methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate.

T Beccari1, C Emiliani, R Hosseini, A Orlacchio, J L Stirling.   

Abstract

4-Methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate was purified from a mixture containing its unsulphated precursor. The substrate was used to test for the presence of functional alpha-subunits in 'intermediate' forms of human beta-N-acetylhexosaminidase in samples of normal and pregnancy serum and in extracts of placenta and lymphocytes from a patient with common acute lymphoblastic leukaemia. Intermediate forms in these samples had no activity towards 4-methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate, indicating that they lack alpha-subunits.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2965573      PMCID: PMC1148068          DOI: 10.1042/bj2440801

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.

Authors:  Y Ben-Yoseph; J E Reid; B Shapiro; H L Nadler
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

2.  Isolation of cDNA clones coding for the beta subunit of human beta-hexosaminidase.

Authors:  B F O'Dowd; F Quan; H F Willard; A M Lamhonwah; R G Korneluk; J A Lowden; R A Gravel; D J Mahuran
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 3.  Cell surface characteristics of human leukaemic cells.

Authors:  M F Greaves
Journal:  Essays Biochem       Date:  1979       Impact factor: 8.000

4.  Expression of hexosaminidase isoenzymes in childhood leukemia.

Authors:  R B Ellis; N T Rapson; A D Patrick; M F Greaves
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

5.  Biochemical and immunochemical characterization of hexosaminidase P.

Authors:  B Geiger; E Calef; R Arnon
Journal:  Biochemistry       Date:  1978-05-02       Impact factor: 3.162

6.  Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.

Authors:  K Inui; D A Wenger
Journal:  Clin Genet       Date:  1984-10       Impact factor: 4.438

7.  N-Acetyl-beta-glucosaminidases in human spleen.

Authors:  D Robinson; J L Stirling
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

8.  Tay-Sachs disease: one-step assay of beta-N-acetylhexosaminidase in serum with a sulphated chromogenic substrate.

Authors:  W Fuchs; R Navon; M M Kaback; H Kresse
Journal:  Clin Chim Acta       Date:  1983-10-14       Impact factor: 3.786

9.  Clearance of human N-acetyl-beta-hexosaminidases from rat circulation.

Authors:  T Bearpark; J L Stirling
Journal:  Biochem J       Date:  1977-12-15       Impact factor: 3.857

Review 10.  The lysosomal hexosaminidase isozymes.

Authors:  D Mahuran; A Novak; J A Lowden
Journal:  Isozymes Curr Top Biol Med Res       Date:  1985
View more
  8 in total

1.  Biochemical characterization of beta-hexosaminidase in different biological specimens from eleven patients with GM2-gangliosidosis B1 variant.

Authors:  M G Ribeiro; R A Pinto; M R Dos Santos; M Maia; M C Sá Miranda
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.

Authors:  M G Ribeiro; T Sonin; R A Pinto; A Fontes; H Ribeiro; E Pinto; M M Palmeira; M C Sá Miranda
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

3.  An enzyme with properties similar to those of beta-N-acetylhexosaminidase S is expressed in the promyelocytic cell line HL-60.

Authors:  C Emiliani; T Beccari; A Tabilio; A Orlacchio; R Hosseini; J L Stirling
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

4.  Treatment of HL-60 cells with dimethyl sulphoxide inhibits the formation of beta-N-acetylhexosaminidase S.

Authors:  C Emiliani; F Falzetti; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

5.  Two new mutations in a late infantile Tay-Sachs patient are both in exon 1 of the beta-hexosaminidase alpha subunit gene.

Authors:  D L Harmon; D Gardner-Medwin; J L Stirling
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

6.  Identification of beta-N-acetylhexosaminidase A in mouse tissues with the fluorigenic substrate 4-methylumbelliferyl-beta-N-acetylglucosamine 6-sulphate.

Authors:  T Beccari; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 7.  Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.

Authors:  Silvia Paciotti; Elisabetta Albi; Lucilla Parnetti; Tommaso Beccari
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

8.  HexA-Enzyme Coated Polymer Nanoparticles for the Development of a Drug-Delivery System in the Treatment of Sandhoff Lysosomal Storage Disease.

Authors:  Eleonora Calzoni; Alessio Cesaretti; Nicolò Montegiove; Alessandro Di Michele; Roberto Maria Pellegrino; Carla Emiliani
Journal:  J Funct Biomater       Date:  2022-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.